Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection.

Research square·2026
Same author

Design and validation of a perfusion bioreactor for long-term human bone explant culture.

JBMR plus·2026
Same author

Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies.

Vaccines·2026
Same author

Human-derived cardiac-neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuron.

The Journal of physiology·2026
Same author

CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancer.

NPJ breast cancer·2026
Same author

Quantitative Assessment of Closure Forces in Paramedian Forehead Flap Donor Sites.

The Journal of craniofacial surgery·2026

Related Experiment Video

Updated: May 3, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.2K

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.

Michael P Pender1, Peter A Csurhes2, Corey Smith3

  • 1The University of Queensland, School of Medicine, Brisbane, Queensland, Australia QIMR Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia m.pender@uq.edu.au.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 5, 2014
PubMed
Summary

Adoptive immunotherapy using Epstein-Barr virus (EBV)-specific CD8(+) T cells improved a multiple sclerosis (MS) patient. This groundbreaking treatment showed clinical benefits and reduced disease activity without adverse effects.

Keywords:
Adoptive immunotherapyB cellCD8+ T cellEpstein–Barr virusmultiple sclerosistreatment

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

18.4K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.1K

Related Experiment Videos

Last Updated: May 3, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.2K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

18.4K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.1K

Area of Science:

  • Immunology
  • Neuroscience
  • Virology

Background:

  • Defective control of Epstein-Barr virus (EBV) by cytotoxic CD8(+) T cells is implicated in multiple sclerosis (MS) pathogenesis.
  • EBV-infected autoreactive B cells accumulating in the central nervous system may contribute to MS.
  • Current MS treatments do not fully address the role of EBV in disease progression.

Observation:

  • A patient with secondary progressive MS was treated with autologous EBV-specific CD8(+) T cells.
  • The T cells were expanded in vitro and targeted EBV latent proteins.
  • This approach represents a novel therapeutic strategy for autoimmune diseases.

Findings:

  • The adoptive immunotherapy was well-tolerated with no adverse effects.
  • The patient experienced clinical improvement and reduced MS disease activity.
  • Magnetic resonance imaging showed decreased lesion burden, and intrathecal immunoglobulin production was reduced.

Implications:

  • This study presents the first use of EBV-specific adoptive immunotherapy for MS.
  • The findings suggest a potential new treatment avenue for autoimmune diseases linked to viral infections.
  • Further research is warranted to explore the efficacy and safety of this therapy in a broader patient population.